 Harmony Biosciences Holdings, Inc. NASDAQ:HRMY Q3 2022 Earnings Conference Call November 1, 2022 8:30 AM ET Company Participants Luis Sanay - Head-Investor Relations John Jacobs - President Chief Executive Officer Jeffrey Dierks - Chief Commercial Officer Jeffrey Dayno - Chief Medical Officer Sandip Kapadia - Chief Financial Officer Conference Call Participants Francois Brisebois - Oppenheimer David Amsellem - Piper Sandler Charles Duncan - Cantor Fitzgerald Corinne Jenkins - Goldman Sachs Chris Howerton - Jefferies Graig Suvannavejh - Mizuho Securities Operator Good morning. My name is Gretchin, and I will be your conference operator today. 